New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 28, 2014
08:15 EDTACST, NEPTNeptune Technologies, Acasti Pharma, NeuroBio announce resignation of CEO
Neptune Technologies & Bioressources (NEPT), Acasti Pharma (ACST) and NeuroBioPharm jointly announce the resignation of Henri Harland as president and CEO of Neptune, Acasti and NeuroBio with immediate effect. Harland remains a director of Neptune, Acasti and NeuroBio. The businesses will continue to be managed by a management and operations committee under the leadership of Neptune's CFO, André Godin. The search for a new president and CEO will commence immediately.
News For NEPT;ACST From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 27, 2015
17:39 EDTNEPTNeptune Technologies sees Q1 revenue approximately $2M, one estimate $6.8M
In line with Neptune's decision to slow production down to address product handling characteristics, consolidated sales for the first quarter ending May 31 are expected to come in at approximately $2M, while the gross margin will remain under pressure. "However, with the positive momentum we are seeing at the plant and a robust sales pipeline we expect sales for the second quarter ending August 31, 2015 to be materially higher," highlighted CEO Jim Hamilton. "Our overriding objectives are to ensure customers receive a premium product and to optimize plant output in a cost effective manner, while building out demand as we increase production."
17:37 EDTNEPTNeptune Technologies reports Q4 net loss ($10.679M) vs. ($1.327M) a year ago
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use